|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation expense | ||||
| Debt issuance costs | ||||
| Operating lease expense | ||||
| Deferred tax expense (benefit) | ||||
| Stock-based compensation | ||||
| Interest expense | ||||
| Change in fair value of financial instruments | ||||
| Loss on debt extinguishment | ||||
| Expenses related to Merger | ||||
| Change in fair value of financial instruments, net of interest paid on Secured Convertible Notes | ||||
| Foreign exchange differences | ||||
| Loss on disposal of property and equipment | ||||
| (Release) expense for estimated credit losses on accounts receivable | ||||
| Equity in net (income) loss of affiliate | ||||
| Non-cash change in contract liabilities | ||||
| Other, net | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| Accounts payable | ||||
| Contract liabilities | ||||
| Accrued expenses and other liabilities | ||||
| Operating lease liabilities | ||||
| Cash paid for interest on Secured Convertible Notes | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchases of property and equipment | ||||
| Proceeds from sale of property and equipment | ||||
| Other | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from issuance of redeemable Series X preferred stock | ||||
| Proceeds from issuance of debt | ||||
| Repurchase of stock | ||||
| Proceeds from Secured Convertible Notes | ||||
| Proceeds from issuance stock | ||||
| At The Market Program | ||||
| PIPE Investment | ||||
| Registered Direct Offering | ||||
| Public Offering | ||||
| Total proceeds from issuance stock | ||||
| Payments of debt issuance costs | ||||
| Payments for withholding taxes related to the net share settlement of equity awards | ||||
| Proceeds from exercise of Public Warrants | ||||
| Proceeds from exercise of stock options | ||||
| Net cash provided by financing activities | ||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||||
| Effect of foreign exchange rate changes | ||||
| Cash, cash equivalents and restricted cash - beginning of period | ||||
| Cash, cash equivalents and restricted cash - end of period |
Loading...
